Dr Michael Doyle
Michael is a Bardi Aboriginal man and Senior Research Fellow at the University of Sydney. Michael joined the AH&MRC Human Research Ethics Committee in 2017 in a research role and became the co-chair during 2021. Michael is passionate about the need for research to be conducted in a culturally appropriate manner from its inception to completion. He hopes that his work with the AH&MRC HREC will contribute to producing higher quality Aboriginal Health Research across New South Wales.
Michael began his health career when he enrolled in the Aboriginal Health Worker (AHW) training program at the Kimberley Aboriginal Medical Services Council in 1997. He has worked as an AHW Trainee in his home community of Djarindjin and as a Men’s Health Worker for the Broome Regional Aboriginal Medical Service and the Derbarl Yerrigan Health Service in Perth. In 2005 Michael began work at the Aboriginal Health Council of Western Australia and helped establish it as the new peak body for Aboriginal Community Controlled Health Services in WA. Michael continues to work closely with colleagues in the ACCHS sector and is a member of his local Aboriginal Medical Service.
Michael moved from the ACCHS sector into the university sector to undertake research in alcohol and other drugs in 2008. He has worked at Curtin University’s National Drug Research Institute and the University of New South Wales’ Kirby Institute. Since 2017, Michael has worked at the University of Sydney’s Centre of Research Excellence in Indigenous Health and Alcohol. Michael has a Certificate IV in Aboriginal Health Work, a Graduate Diploma of Indigenous Health Promotion (University of Sydney), a Master of Public Health (University of Western Australia) and was awarded his Doctor of Philosophy in 2018 (University of New South Wales). His PhD focused on prison-based alcohol and other drug treatment for men, and he continues to conduct research in the field. Michael commenced a National Health and Medical Research Council; Investigator Grant, Emerging Leadership in 2022.